Ledger.Open graph →
SEC Form D · filed March 19, 2024

Avidity Biosciences, Inc

Offering
$400.2M
Sold
$400.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Troy M. Wilson · San Diego, CADirectorW. M. Flanagan · San Diego, CAExecNoreen M. Henig · San Diego, CADirectorCarsten M. Boess · San Diego, CADirectorTamar M. Thompson · San Diego, CADirectorSarah Boyce · LA JOLLA, CAExec · DirectorTeresa M. Mccarthy · San Diego, CAExecEdward M. Kaye · San Diego, CADirectorJean M. Kim · San Diego, CADirectorArthur Levin · San Diego, CAExecMichael M. Maclean · San Diego, CAExecNoreen M. Henig · San Diego, CADirectorCarsten M. Boess · San Diego, CADirectorTroy M. Wilson · San Diego, CADirectorTamar M. Thompson · San Diego, CADirectorSarah Boyce · LA JOLLA, CAExec · DirectorTeresa M. Mccarthy · San Diego, CAExecEdward M. Kaye · San Diego, CADirectorJean M. Kim · San Diego, CADirectorW. M. Flanagan · San Diego, CAExecArthur Levin · San Diego, CAExecMichael M. Maclean · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗